Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bollschweiler

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
British Journal of Cancer|June 24, 2004
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancerF Miyazono, R Metzger, U Warnecke-Eberz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2018
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre studyL C Hewitt, I Z Inam, Y Saito, et al.
Zentralblatt Fur Chirurgie|August 19, 2009
[Diagnosis of and therapy for gastric cancer--work-flow]R T Grundmann, A H Hölscher, A Bembenek, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
British Journal of Cancer|June 24, 2004
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancerF Miyazono, R Metzger, U Warnecke-Eberz, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2018
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre studyL C Hewitt, I Z Inam, Y Saito, et al.
Zentralblatt Fur Chirurgie|August 19, 2009
[Diagnosis of and therapy for gastric cancer--work-flow]R T Grundmann, A H Hölscher, A Bembenek, et al.
Pageof 9